Submit Deal

ALCON INC

Summary

Alcon manufactures eye care products. The Company produces and markets vitreoretinal and cataract surgery, contact lenses, and refractive technology products. Alcon serves medical industry worldwide.

Deals Overview

Total Deals5

Valued Deals5

Total Value£ 21.78 B

Avg. Deal Size£ 4.36 B

Market Context

Senior Management

David Endicott
CEO
David Murray
CFO
Timothy C. Stonesifer
CFO

Sort

29 Jun 2018|Switzerland|Medical Equipment

Target: ALCON INC

Bidder: INSTITUTIONAL INVESTORS

9 Service Providers

3 Target | 6 Vendor

92 Dealmakers

3 Target | 89 Vendor

£ 20.63 B

Value

08 Nov 2021|United States|Medical Equipment

Target: IVANTIS INC

Bidder: ALCON INC

2 Service Providers

1 Target | 1 Bidder

8 Dealmakers

2 Target | 6 Bidder

£ 352 M

Value

12 Apr 2022|United States|Health Care Services

Target: AURION BIOTECH

Bidder: DEERFIELD MANAGEMENT COMPANY

6 Service Providers

1 Target | 5 Bidder

7 Dealmakers

2 Target | 5 Bidder

£ 92 M

Value

23 May 2022|United States|Pharmaceuticals

Target: EYSUVIS

Bidder: ALCON INC

5 Service Providers

1 Bidder | 4 Vendor

6 Dealmakers

3 Bidder | 3 Vendor

£ 48 M

Value

22 Aug 2022|United States|Pharmaceuticals

Target: AERIE PHARMACEUTICALS INC

Bidder: ALCON INC

9 Service Providers

5 Target | 4 Bidder

58 Dealmakers

33 Target | 25 Bidder

£ 650 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy